Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication ...

Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

NL Health Services’ provincial Comprehensive Respiratory Care (CRC) team established a partnership with the health-care team ...

it is quickly becoming a promising tool for patient adherence, chronic disease management, preventive medicine, rehabilitation, and paediatric care, as well as for medical education, training ...

Alex Kent Hi, my name’s Alex Kent. I’m medical director for North East and North Cumbria ICB and I cover long term conditions as part of my portfolio. I also work part time as a GP in North Tyneside.

Alex Kent Hi, my name’s Alex Kent. I’m medical director for North East and North Cumbria ICB and I cover long term conditions as part of my portfolio. I also work part time as a GP in North Tyneside.

The report calls for greater access to multiple treatment options so patients can learn to manage their pain. But, Mackey said in an interview, “It’s what our system is least equipped to do.